A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats

Vascular Pharmacology

Volumn 50, Issue 5-6, 2009, Pages 185-193

  Song, Jinye ^a,b,c   Meng, Liqiang ^a,b,c   Li, Shen ^a,b,c   Qu, Lei ^a,b,c   Li, Xiaomei ^a,b,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Angelica; Astragalus; Proteinuria; Vascular endothelial growth factor

Indexed keywords

AMINOPEPTIDASE P; ANGELICA SINENSIS EXTRACT; ASTRAGALUS MEMBRANACEUS MONGHOLICUS EXTRACT; COLLAGEN TYPE 4; CREATININE; ENALAPRIL; FIBRONECTIN; PLANT EXTRACT; UNCLASSIFIED DRUG; UREA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY DENSITY; CHINESE HERB; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD VESSEL; KIDNEY CORTEX; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TUBULE DISORDER; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; QUANTITATIVE ANALYSIS; RAT; RENAL PROTECTION; TREATMENT RESPONSE; UPREGULATION; UREA BLOOD LEVEL; URINARY EXCRETION;

AMINOPEPTIDASES; ANGELICA SINENSIS; ANIMALS; ASTRAGALUS MEMBRANACEUS; COLLAGEN; CREATININE; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; ENALAPRIL; FIBRONECTINS; KIDNEY; MALE; MICROVESSELS; NEPHRECTOMY; PROTEINURIA; RANDOM ALLOCATION; RATS; RATS, WISTAR; RENAL INSUFFICIENCY; UREA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 61349181342     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2009.01.005     Document Type: Article

References (44)

1. Abbate M., Zoja C., and Remuzzi G. How does proteinuria cause progressive renal damage?. J. Am. Soc. Nephrol. 17 (2006) 2974-2984
2. Adamczak M., Gross M.L., Krtil J., Koch A., Tyralla K., Amann K., and Ritz E. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. J. Am. Soc. Nephrol. 14 (2003) 2833-2842
3. Brown L.F., Berse B., Tognazzi K., Manseau E.J., Van de Water L., Senger D.R., Dvorak H.F., and Rosen S. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int. 42 (1992) 1457-1461
4. Choi Y.J., Chakraborty S., Nguyen V., Nguyen C., Kim B.K., Shim S.I., Suki W.N., and Truong L.D. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum. Pathol. 31 (2000) 1491-1497
5. D'Amico G., and Bazzi C. Pathophysiology of proteinuria. Kidney Int. 63 (2003) 809-825
6. el Nahas A.M., Bassett A.H., Cope G.H., and Le Carpentier J.E. Role of growth hormone in the development of experimental renal scarring. Kidney Int. 40 (1991) 29-34
7. Fan L., Wakayama T., Yokoyama S., Amano O., and Iseki S. Downregulation of vascular endothelial growth factor and its receptors in the kidney in rats with puromycin aminonucleoside nephrosis. Nephron 90 (2002) 95-102
8. Floege J., Alpers C.E., Burns M.W., Pritzl P., Gordon K., Couser W.G., and Johnson R.J. Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab. Invest. 66 (1992) 485-497
9. Futrakul N., Butthep P., Laohareungpanya N., Chaisuriya P., and Ratanabanangkoon K. A defective angiogenesis in chronic kidney disease. Ren. Fail. 30 (2008) 215-217
10. Griffin K.A., Picken M., and Bidani A.K. Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J. Am. Soc. Nephrol. 4 (1994) 2023-2031
11. Haas C.S., Câmpean V., Kuhlmann A., Dimmler A., Reulbach U., Forster C., Aigner T., Acker T., Plate K., and Amann K. Analysis of glomerular VEGF mRNA and protein expression in murine mesangioproliferative glomerulonephritis. Virchows Arch. 450 (2007) 81-92
12. Ishii Y., Sawada T., Kubota K., Fuchinoue S., Teraoka S., and Shimizu A. Injury and progressive loss of peritubular capillaries in the development of chronic allograft nephropathy. Kidney Int. 67 (2005) 321-332
13. Kakinuma Y., Kawamura T., Bills T., Yoshioka T., Ichikawa I., and Fogo A. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int. 42 (1992) 46-55
14. Kanazawa M., Kawamura T., Li L., Sasaki Y., Matsumoto K., Kataoka H., Ito O., Minami N., Sato T., Ootaka T., and Kohzuki M. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation. Am. J. Hypertens. 19 (2006) 80-86
15. Kang D.H., and Johnson R.J. Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis. Curr. Opin. Nephrol. Hypertens. 12 (2003) 43-49
16. Kang D.H., Hughes J., Mazzali M., Schreiner G.F., and Johnson R.J. Impaired angiogenesis in the remnant kidney model. II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol. 12 (2001) 1448-1457
17. Kang D.H., Joly A.H., Oh S.W., Hugo C., Kerjaschki D., Gordon K.L., Mazzali M., Jefferson J.A., Hughes J., Madsen K.M., Schreiner G.F., and Johnson R.J. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J. Am. Soc. Nephrol. 12 (2001) 1434-1447
18. Kawamura K., Okada S., Li B., Suwa M., Yao J., Morioka T., Gejyo F., and Oite T. Turbulence of glomerular hemodynamics involved in progressive glomerulosclerosis. Kidney Int. 69 (2006) 1792-1798
19. Konopka C.L., Jurach A., and Wender O.C. Experimental model for the study of chronic renal ischemia in rats: morphologic, histological and ultra-structural analysis. Acta Cir. Bras. 22 (2007) 12-21
20. Kren S., and Hostetter T.H. The course of the remnant kidney model in mice. Kidney Int. 56 (1999) 333-337
21. Kretzler M., Schröppel B., Merkle M., Huber S., Mundel P., Horster M., and Schlöndorff D. Detection of multiple vascular endothelial growth factor splice isoforms in single glomerular podocytes. Kidney Int. Suppl. 67 (1998) S159-S161
22. Krivosíková Z., Sebeková K., Spustová V., Lajdová I., and Dzúrik R. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat. Physiol. Res. 48 (1999) 429-435
23. Lafayette R.A., Mayer G., Park S.K., and Meyer T.W. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90 (1992) 766-771
24. Li X., and Wang H. Chinese herbal medicine in the treatment of chronic kidney disease. Adv. Chronic Kidney Dis. 12 (2005) 276-281
25. Liu E., Morimoto M., Kitajima S., Koike T., Yu Y., Shiiki H., Nagata M., Watanabe T., and Fan J. Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions. J. Am. Soc. Nephrol. 18 (2007) 2094-2104
26. Ma L.J., Nakamura S., Aldigier J.C., Rossini M., Yang H., Liang X., Nakamura I., Marcantoni C., and Fogo A.B. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J. Am. Soc. Nephrol. 16 (2005) 966-976
27. Manotham K., Tanaka T., Matsumoto M., Ohse T., Miyata T., Inagi R., Kurokawa K., Fujita T., and Nangaku M. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J. Am. Soc. Nephrol. 15 (2004) 1277-1288
28. Masuda Y., Shimizu A., Mori T., Ishiwata T., Kitamura H., Ohashi R., Ishizaki M., Asano G., Sugisaki Y., and Yamanaka N. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am. J. Pathol. 159 (2001) 599-608
29. Matsumoto M., Tanaka T., Yamamoto T., Noiri E., Miyata T., Inagi R., Fujita T., and Nangaku M. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J. Am. Soc. Nephrol. 15 (2004) 1574-1581
30. Meng L., Qu L., Tang J., Cai S.Q., Wang H., and Li X. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, enhanced nitric oxide production in obstructed rat kidney. Vascul. Pharmacol. 47 (2007) 174-183
31. Miyamoto K., Kitamoto Y., Tokunaga H., Takeya M., Ezaki T., Imamura T., and Tomita K. Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab. Invest. 84 (2004) 1126-1136
32. Mizobuchi M., Morrissey J., Finch J.L., Martin D.R., Liapis H., Akizawa T., and Slatopolsky E. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J. Am. Soc. Nephrol 18 (2007) 1796-1806
33. Monacci W.T., Merrill M.J., and Oldfield E.H. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264 (1993) C995-C1002
34. Norman J.T., and Fine L.G. Intrarenal oxygenation in chronic renal failure. Clin. Exp. Pharmacol. Physiol. 33 (2006) 989-996
35. Sahai A., Mei C., Schrier R.W., and Tannen R.L. Mechanisms of chronic hypoxia-induced renal cell growth. Kidney Int. 56 (1999) 277-1281
36. Santos L.S., Chin E.W., Ioshii S.O., and Tambara Filho R. Surgical reduction of the renal mass in rats: morphologic and functional analysis on the remnant kidney. Acta Cir. Bras. 21 (2006) 252-257
37. Schrijvers B.F., Flyvbjerg A., Tilton R.G., Rasch R., Lameire N.H., and De Vriese A.S. Pathophysiological role of vascular endothelial growth factor in the remnant kidney. Nephron. Exp. Nephrol. 101 (2005) e9-e15
38. Sheng M.X., Li J.Z., and Wang H.Y. Therapeutic effect of Astragalus and Angelica on renal injury induced by ischemia/reperfusion in rats (Chinese). Zhongguo Zhong Xi Yi Jie He Za Zhi 21 (2001) 43-46
39. Shimizu A., Masuda Y., Mori T., Kitamura H., Ishizaki M., Sugisaki Y., and Fukuda Y. Vascular endothelial growth factor 165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J. Am. Soc. Nephrol. 15 10 (2004) 2655-2665
40. Véniant M., Heudes D., Clozel J.P., Bruneval P., and Ménard J. Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats. Kidney Int. 46 (1994) 421-429
41. Wang H.Y. Effects of capitalized wilfordii, angelica and astragalus on glomerular permeability in rats with minimal change nephropathy (Chinese). Zhonghua Yi Xue Za Zhi 68 (1988) 513-515
42. Wang H., Li J., Yu L., Zhao Y., and Ding W. Antifibrotic effect of the Chinese herbs, Astragalus mongholicus and Angelica sinensis, in a rat model of chronic puromycin aminonucleoside nephrosis. Life Sci. 74 (2004) 1645-1658
43. Yamamoto M., Fukui M., Shou I., Wang L.N., Sekizuka K., Suzuki S., Shirato I., and Tomino Y. Effects of treatment with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor antagonist (AIIRA) on renal function and glomerular injury in subtotal nephrectomized rats. J. Clin. Lab. Anal. 11 (1997) 53-62
44. Zhao J.R., Qu L., and Li X.M. Preventive and therapeutic effects of astragalus and angelica mixture on renal tubulointerstitial fibrosis after unilateral ureteral obstruction in rats (Chinese). Beijing Da Xue Xue Bao 36 (2004) 119-123